AC
AGN

Avestar Capital’s Allergan plc AGN Stock Holding History

Avestar Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,130
Closed -$200K – 208
2020
Q1 		$200K Sell
1,130
-15
-1% -$2.82K 0.11% 152
2019
Q4 		$218K Sell
1,145
-144
-11% -$26K 0.12% 151
2019
Q3 		$217K Sell
1,289
-237
-16% -$38.6K 0.13% 146
2019
Q2 		$238K Buy
1,526
+51
+3% +$7.06K 0.15% 92
2019
Q1 		$191K Buy
1,475
+65
+5% +$9.42K 0.13% 110
2018
Q4 		$167K Sell
1,410
-153
-10% -$25.1K 0.11% 111
2018
Q3 		$277K Buy
1,563
+80
+5% +$14.7K 0.16% 77
2018
Q2 		$230K Buy
1,483
+298
+25% +$47.8K 0.15% 96
2018
Q1 		$183K Buy
1,185
+374
+46% +$62.7K 0.12% 97
2017
Q4 		$113K Buy
+811
New +$146K 0.08% 139

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Avestar Capital's AGN Position: Q2 2020 in Review

Avestar Capital sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,130 shares — an estimated $200K sold.

Avestar Capital first reported a position in AGN in Q4 2017 and held it in 10 quarters. The position peaked at $277K in Q3 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Avestar Capital reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Avestar Capital sold 1,130 Allergan plc shares in Q2 2020, an estimated $200K.
  • Avestar Capital first reported a position in Allergan plc in Q4 2017 and held it in 10 quarters.
  • Avestar Capital's Allergan plc position peaked at $277K in Q3 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Avestar Capital's 13F filing for Q2 2020, filed 29 Jul 2020.